Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Revive Therapeutics Ltd (RVV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0300 +0.0000    +0.00%
11:32:00 - Delayed Data. Currency in CAD ( Disclaimer )
  • Volume: 40,925
  • Bid/Ask: 0.0250 / 0.0300
  • Day's Range: 0.0250 - 0.0300
Type:  Equity
Market:  Canada
Revive Therapeutics 0.0300 +0.0000 +0.00%

RVV Earnings

 
The latest earnings per stock, revenues and financial reports for Revive Therapeutics Ltd (RVV).
InvestingPro Earnings Insights
Latest Release

Feb 28, 2024

EPS / Forecast

-- / --

Revenue / Forecast

-- / --

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
May 27, 2024 03/2024 -- /  -- -- /  --
Feb 28, 2024 12/2023 -- /  -- -- /  --
Nov 30, 2023 09/2023 -- /  -- -- /  --
Oct 28, 2023 06/2023 -- /  -- -- /  --
May 30, 2023 03/2023 -- /  -- -- /  --
Mar 01, 2023 12/2022 -0 /  -- -- /  --
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RVV Comments

Write your thoughts about Revive Therapeutics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Ivanitz
Mike Ivanitz Nov 26, 2021 12:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold
Mike Ivanitz
Mike Ivanitz Jul 14, 2021 10:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No selling
Joshua Adesiyan
Joshua Adesiyan Mar 09, 2021 10:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
50% day love it
spiro papadatos
spiro papadatos Mar 09, 2021 10:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a bargain. thank you all
Joshua Adesiyan
Joshua Adesiyan Mar 05, 2021 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fun stuff
Joshua Adesiyan
Joshua Adesiyan Feb 17, 2021 10:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they just bought some Psilocybin related research
Joshua Adesiyan
Joshua Adesiyan Feb 11, 2021 10:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
noice
Dan Jackson
Dan Jackson Feb 04, 2021 14:17
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whats the deal here?
Joshua Adesiyan
Joshua Adesiyan Jan 24, 2021 13:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hoping for a big week !
Babar Abbasi
Babar Abbasi Jan 12, 2021 11:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mary joy what u think ACDC
Mary Joy Mrvchk
Mary Joy Mrvchk Jan 11, 2021 8:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
babar abhasi, i hope u already bought nio
Babar Abbasi
Babar Abbasi Jan 11, 2021 8:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no brother i miss it
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email